Clinical Trial Update: Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)

View source ↗

Summary

A real-world, prospective multicenter study in France evaluating the Omnipod-5 automated insulin delivery system for Type 1 diabetes; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Omnipod 5

Snippet

Sponsor: Insulet Corporation | Conditions: Diabetes, Type 1 Diabetes | Status: RECRUITING